Renew® ECP is Now Indicated for Healthy Patients

News provided by

Jun 21, 2016, 10:30 ET

FARMINGTON HILLS, Mich., June 21, 2016 /PRNewswire/ -- Renew Group Private Limited (RGPL) today announced that The Renew® External Counterpulsation (ECP) Therapy System received a new clearance from the FDA for the treatment of healthy individuals. In addition to the well-known indication for the treatment of chronic stable angina, the Renew® ECP Therapy System is also "intended for use in healthy patients to provide improvement in vasodilation, increased VO2 and increased blood flow." The Renew® NCP-5 is the only ECP system with a cleared indication for the use in healthy patients.

Renew® ECP Therapy increases blood flow, vasodilation, and VO2 by enhancing blood flow throughout the body. During treatment, the patient's legs are compressed in coordination with the heart cycle. When the heart is at rest, this compression forces blood back to the heart and throughout the entire vascular system. This "counterpulsation" acts as an auxiliary pump benefitting the entire cardiovascular system and has been clinically proven to improve an individual's tolerance for activity¹.

"There's a need from the patient base and we, as medical professionals, need to seek out technology to help solve the concerns and problems of our patients. Renew ECP Therapy is one of those technology pieces that patients are seeking," said Asif Ali, M.D., clinical assistant professor at the University of Texas Health Science Center and consultant for Lifeline Sciences.

For more information, visit www.renewecpusa.com.

Renew® ECP Therapy is a non-invasive approach for treating chronic stable angina and improving vasodilation, VO2,and blood flow in healthy patients It improves blood flow by gently squeezing the blood from the lower body toward the heart. Here's how it works: Inflatable cuffs (like blood pressure cuffs) are wrapped around the calves, thighs and hips. Between heartbeats the cuffs inflate and deflate in rapid succession from the calves up to the hips. These external pulses speed the blood through the arteries and veins toward the heart, thus improving circulation in and around the heart. Renew® ECP Therapy is intended for use under the oversight of a healthcare professional and requires a prescription for treatment.

Dr. Asif is a Clinical Assistant Professor at University of Texas Health Science Center. He has authored many academic journals and presents in national and international meetings as a faculty speaker. He has authored a cardiology book published by McGraw Hill. He has been featured nationally on the Dr. Oz show, Fox and Friends, Channel 8 Bill of Health, and Discovery Channel. He works as a physician partner with the Houston Rockets organization.

He has served as Chief Medical Officer, Chief of Cardiology, and Chief of Education for various Houston hospitals.

Renew is a registered trademark of Renew Group Private Limited.

¹ Arora RR, et al. Effects of Enhanced External Counterpulsation on Health-Related Quality of Life Continue 12 Months After Treatment: A Substudy of the Multicenter Study of Enhanced External Counterpulsation. Journal of Investigative Medicine. 2002;50:25-32.